BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23578443)

  • 1. [Whole-genome messenger RNA profiling reveals genes involved in malignant progression of glioma].
    Yang P; Yan W; Zhang W; You G; Bao ZS; Jiang T
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(1):5-7. PubMed ID: 23578443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
    Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
    Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Establishment of malignant progression associated gene expression profiles in human brain glioma].
    Huang Q; Dong J; Wang AD; Shao NY; Sun JY; Li XN; Lan Q; Hu GX
    Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):437-40. PubMed ID: 14575564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide small noncoding RNA profiling of pediatric high-grade gliomas reveals deregulation of several miRNAs, identifies downregulation of snoRNA cluster HBII-52 and delineates H3F3A and TP53 mutant-specific miRNAs and snoRNAs.
    Jha P; Agrawal R; Pathak P; Kumar A; Purkait S; Mallik S; Suri V; Chand Sharma M; Gupta D; Suri A; Sharma BS; Julka PK; Kulshreshtha R; Sarkar C
    Int J Cancer; 2015 Nov; 137(10):2343-53. PubMed ID: 25994230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gene expression profiling of malignant gliomas by cDNA microarrays].
    Takahashi H; Kouno J
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():515-9. PubMed ID: 16201574
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cluster analysis and identify significance of novel genes related to glioma in molecule classification].
    Chen JX; Lu YC; Ying K; Ding XH; Hu GH; Luo C; Lou MQ; Li Y; Tang R; Xie Y
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(8):622-7. PubMed ID: 15130299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-grade glioma: can we teach an old dogma new tricks?
    Gilbertson RJ
    Cancer Cell; 2006 Mar; 9(3):147-8. PubMed ID: 16530697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma.
    Foltz G; Ryu GY; Yoon JG; Nelson T; Fahey J; Frakes A; Lee H; Field L; Zander K; Sibenaller Z; Ryken TC; Vibhakar R; Hood L; Madan A
    Cancer Res; 2006 Jul; 66(13):6665-74. PubMed ID: 16818640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary study on differentiation-inducing associated genes of human brain glioma cells in vitro].
    Huang Q; Sun LJ; Dong J; Li XN; Wang AD; Lan Q
    Ai Zheng; 2003 Jul; 22(7):673-9. PubMed ID: 12866954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and characterizations of a novel full-length gene PKIbeta related to human glioma].
    Qi ZY; Hui GZ; Li Y; Gu SH; Xie Y
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(25):1778-82. PubMed ID: 19035091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of pituitary tumor-transforming gene (PTTG)-1 is correlated with poor prognosis in glioma patients.
    Genkai N; Homma J; Sano M; Tanaka R; Yamanaka R
    Oncol Rep; 2006 Jun; 15(6):1569-74. PubMed ID: 16685397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.
    Tu Y; Gao X; Li G; Fu H; Cui D; Liu H; Jin W; Zhang Y
    Cancer Res; 2013 Oct; 73(19):6046-55. PubMed ID: 23950210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of histological markers for malignant glioma by genome-wide expression analysis: dynein, alpha-PIX and sorcin.
    Yokota T; Kouno J; Adachi K; Takahashi H; Teramoto A; Matsumoto K; Sugisaki Y; Onda M; Tsunoda T
    Acta Neuropathol; 2006 Jan; 111(1):29-38. PubMed ID: 16320026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A blood-based gene expression and signaling pathway analysis to differentiate between high and low grade gliomas.
    Ponnampalam SN; Kamaluddin NR; Zakaria Z; Matheneswaran V; Ganesan D; Haspani MS; Ryten M; Hardy JA
    Oncol Rep; 2017 Jan; 37(1):10-22. PubMed ID: 28004117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Identification of novel genes related to glioma by oligonucleotide microarray].
    Liu S; Tian ZM; Zheng GQ; Wu HT; Jin YB; Ma X; Fan WH; Fan M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):182-5. PubMed ID: 17407077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
    Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution genome-wide mapping of genetic alterations in human glial brain tumors.
    Bredel M; Bredel C; Juric D; Harsh GR; Vogel H; Recht LD; Sikic BI
    Cancer Res; 2005 May; 65(10):4088-96. PubMed ID: 15899798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcellular distribution and expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in malignant glioma: Influence on cell survival and migration.
    Borsics T; Lundberg E; Geerts D; Koomoa DL; Koster J; Wester K; Bachmann AS
    Cancer Sci; 2010 Jul; 101(7):1624-31. PubMed ID: 20412121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-cell RNA sequencing reveals immunosuppressive myeloid cell diversity during malignant progression in a murine model of glioma.
    Rajendran S; Hu Y; Canella A; Peterson C; Gross A; Cam M; Nazzaro M; Haffey A; Serin-Harmanci A; Distefano R; Nigita G; Wang W; Kreatsoulas D; Li Z; Sepeda JA; Sas A; Hester ME; Miller KE; Elemento O; Roberts RD; Holland EC; Rao G; Mardis ER; Rajappa P
    Cell Rep; 2023 Mar; 42(3):112197. PubMed ID: 36871221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma.
    Gressot LV; Doucette T; Yang Y; Fuller GN; Manyam G; Rao A; Latha K; Rao G
    Oncotarget; 2017 Feb; 8(8):12695-12704. PubMed ID: 27074575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.